» Articles » PMID: 31208841

Regulatory Interplay Between Deubiquitinating Enzymes and Cytokines

Overview
Date 2019 Jun 19
PMID 31208841
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Deubiquitinating enzymes (DUBs) are cysteine protease proteins that reverse the ubiquitination by removing ubiquitins from the target protein. With over 100 DUBs identified and categorized into at least 7 families, many DUBs interact with one or more cytokines, influencing cellular processes, such as antiviral responses, inflammatory responses, apoptosis, etc. While some DUBs influence cytokine pathway or production, some DUBs are cytokine-inducible. In this article, we summarize a list of DUBs, their interaction with cytokines, target proteins and mechanisms of action.

Citing Articles

Ubiquitin-Proteasome System in Periodontitis: Mechanisms and Clinical Implications.

Ma Y, Jia R, Chen S, Ma J, Yin L, Pan X Cell Prolif. 2024; 58(3):e13781.

PMID: 39626954 PMC: 11882760. DOI: 10.1111/cpr.13781.


Roles of ubiquitin-specific proteases in inflammatory diseases.

Chen R, Zhang H, Li L, Li J, Xie J, Weng J Front Immunol. 2024; 15:1258740.

PMID: 38322269 PMC: 10844489. DOI: 10.3389/fimmu.2024.1258740.


AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification.

Wang H, Liu J, Zhu X, Yang B, He Z, Yao X Research (Wash D C). 2023; 6:0252.

PMID: 37854295 PMC: 10581371. DOI: 10.34133/research.0252.


Deep-learning based approach to identify substrates of human E3 ubiquitin ligases and deubiquitinases.

Shu Y, Hai Y, Cao L, Wu J Comput Struct Biotechnol J. 2023; 21:1014-1021.

PMID: 36733699 PMC: 9883182. DOI: 10.1016/j.csbj.2023.01.021.


Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Chen S, Liu Y, Zhou H Int J Mol Sci. 2021; 22(9).

PMID: 33925279 PMC: 8123678. DOI: 10.3390/ijms22094546.


References
1.
Boone D, Turer E, Lee E, Ahmad R, Wheeler M, Tsui C . The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004; 5(10):1052-60. DOI: 10.1038/ni1110. View

2.
Baek K, Kim M, Kim Y, Shin J, Choi H . DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. J Biol Chem. 2003; 279(4):2368-76. DOI: 10.1074/jbc.M304774200. View

3.
Opipari Jr A, Boguski M, Dixit V . The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem. 1990; 265(25):14705-8. View

4.
Zhu Y, Carroll M, Papa F, Hochstrasser M, DAndrea A . DUB-1, a deubiquitinating enzyme with growth-suppressing activity. Proc Natl Acad Sci U S A. 1996; 93(8):3275-9. PMC: 39596. DOI: 10.1073/pnas.93.8.3275. View

5.
Luong L, Fragiadaki M, Smith J, Boyle J, Lutz J, Dean J . Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination. Circ Res. 2013; 112(12):1583-91. PMC: 7611065. DOI: 10.1161/CIRCRESAHA.111.300119. View